HeadlineShine

Dr Reddy's bets on generic semaglutide, biosimilars

Economic Times ·First reported
Economic TimesDr Reddy's bets on generic semaglutide, biosimilars
Image: Economic Times

Dr Reddy's domestic formulations business grew in the September quarter, while Revlimid sales declined in North America. A relaunch of generic semaglutide and the US launch of abatacept biosimilar are anticipated for future growth. The company aims to sell…

Summary from Economic Times

Read the full story on Economic Times
React

Related stories

Mint
Mint·

Dr Reddy’s Q2 profit falls 36%, plans semaglutide relaunch in November
Economic Times
BusinessEconomic Times·

Dr Reddy's rolls out new generic Ozempic brands
Economic Times
BusinessEconomic Times·

Dr Reddys Share Price Live Updates: Dr. Reddys Breaks Through Resistance Level

More business

See all →
NDTV Profit
Business7 sources·

Rahul Gandhi's convoy collides on expressway
Hindustan Times
Business3 sources·

Fire reported near North Block in Delhi, six fire tenders rushed to scene
NDTV
Business6 sources·

Kharge makes 'baap' remark on Modi; BJP hits back
Economic Times
Business3 sources·

BPCL Q4 Review: Citi, Jefferies Maintain Buy After Q2 Results; Jefferies Cuts Target Price
Economic Times
Business7 sources·

IndiGo, Air India Group To Shift Flights To Navi Mumbai Airport
Mint
Business2 sources·

Tonbo Imaging shares soar another 17% after a 64% listing pop. Buy, sell or hold the stock?

Top stories in India

See all →
The Hindu
3 sources·

Rahul Gandhi acquitted in 2018 defamation case over remarks against Amit Shah, says Congress
NDTV
Sports2 sources·

99 runs leaked in 2 T20Is! Bhuvneshwar Kumar gets a message from Morne Morkel
Times of India
Sports4 sources·

Harmanpreet, Deepti on fire as India seals emphatic series win against Zimbabwe
NDTV Profit
Business2 sources·

Coforge Q2 Review: ICICI Securities Raises Target Price On Strong Growth Outlook; Details Inside
The Hindu
Sports2 sources·

'We've got bulletproof plan for everyone, including Bumrah': Morkel on workload issue
Economic Times
Business2 sources·

Rupee falls 5 paise to 94.98 against U.S. dollar in early trade